Effect of exenatide on cortisol secretion

Trial Profile

Effect of exenatide on cortisol secretion

Phase of Trial: Phase IV

Latest Information Update: 09 May 2018

At a glance

  • Drugs Exenatide (Primary)
  • Indications Metabolic disorders; Obesity; Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 May 2018 Status changed from recruiting to completed.
    • 06 Sep 2017 Status changed from not yet recruiting to recruiting.
    • 22 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top